| Drug Name |
Fluticasone |
| Drug ID |
BADD_D00945 |
| Description |
Fluticasone is a synthetic glucocorticoid available as 2 esters, [DB08906] and [DB00588][F4355,F4358,F4361,F4364][FDA Label]. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications[F4355,F4358,F4361,F4364][FDA Label]. [DB00588] was first approved in 1990[L5962] and [DB08906] was approved in 2007[L5965]. |
| Indications and Usage |
Fluticasone's 2 esters are indicated as inhalers for the treatment and management of asthma by prophylaxis[FDA Label][F4364]as well as inflammatory and pruritic dermatoses[F4355]. A [DB00588] nasal spray is indicated for managing nonallergic rhinitis[F4358] while the [DB08906] nasal spray is indicated for treating season and perennial allergic rhinitis[F4361,A177130]. |
| Marketing Status |
approved; experimental |
| ATC Code |
D07AC17; R01AD08; R03BA05 |
| DrugBank ID |
DB13867
|
| KEGG ID |
D07981
|
| MeSH ID |
D000068298
|
| PubChem ID |
5311101
|
| TTD Drug ID |
D0LC6K
|
| NDC Product Code |
61919-004; 61919-620; 61919-611 |
| UNII |
CUT2W21N7U
|
| Synonyms |
Fluticasone | Flonase | Flovent HFA | HFA, Flovent | Cutivate | Fluticasone Propionate | Propionate, Fluticasone | Flixonase | Flixotide | Flovent |
